Technological Innovations Fuel Growth in the Global COPD Devices Market| AstraZeneca Plc Orion Corporation ,Mylan N.V.,Boehringer Ingelheim GmbH

2 minutes, 47 seconds Read

The COPD devices market refers to the segment of the healthcare industry that focuses on the development, manufacturing, and distribution of medical devices used in the management and treatment of Chronic Obstructive Pulmonary Disease (COPD). COPD is a chronic lung disease characterized by progressive airflow limitation, making it difficult for individuals to breathe properly.

COPD devices play a crucial role in helping individuals with COPD manage their symptoms, improve their lung function, and enhance their quality of life. These devices are designed to deliver medication, provide supplemental oxygen, assist with breathing exercises, and support pulmonary rehabilitation efforts.

The COPD devices market encompasses a wide range of products, including inhalers, nebulizers, oxygen therapy devices, pulmonary rehabilitation equipment, and more. These devices are developed by medical device manufacturers and are regulated by health authorities to ensure their safety and efficacy.

The market for COPD devices has been growing steadily due to several factors. Firstly, the increasing prevalence of COPD worldwide has led to a higher demand for effective treatment options. According to the World Health Organization (WHO), COPD is currently the third leading cause of death globally. Additionally, the aging population and rising exposure to risk factors such as smoking and environmental pollution contribute to the growing burden of COPD.

Request a Sample Copy of the Report for In-Depth Market Insights:

The COPD (Chronic Obstructive Pulmonary Disease) devices market can be segmented based on various factors. Here are some common segmentation approaches used in the industry:

Product Type:

  1. Inhalers: This category includes metered dose inhalers (MDIs), dry powder inhalers (DPIs), and soft mist inhalers (SMIs).
  2. Nebulizers: It includes jet nebulizers, ultrasonic nebulizers, and mesh nebulizers.
  3. Oxygen Systems: This category comprises portable oxygen concentrators, oxygen cylinders, and liquid oxygen systems.
  4. Positive Airway Pressure (PAP) Devices: It includes Continuous Positive Airway Pressure (CPAP) devices, Bi-level Positive Airway Pressure (BiPAP) devices, and Adaptive Servo-Ventilation (ASV) devices.
  5. Others: This category can include devices like spirometers, peak flow meters, and airway clearance systems.

End User:

  1. Hospitals and Clinics: Devices used in healthcare settings, including hospitals, clinics, and specialized COPD treatment centers.
  2. Homecare Settings: Devices designed for use in patients’ homes, enabling self-management of COPD.
  3. Ambulatory Surgical Centers: Devices used in ambulatory surgical centers or outpatient facilities.


The market can be segmented based on regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Regional factors like prevalence of COPD, healthcare infrastructure, reimbursement policies, and market dynamics can influence device usage and market demand.

Disease Severity:

This segmentation can consider the different stages of COPD severity, such as mild, moderate, severe, and very severe. Devices may vary based on disease severity and the specific needs of patients at different stages.

Distribution Channel:

  1. Retail Pharmacies: Devices available over the counter in retail pharmacy outlets.
  2. Online Pharmacies: Devices sold through online platforms.
  3. Hospital Pharmacies: Devices dispensed through hospital-based pharmacies.
  4. Others: Specialty stores or dedicated medical supply stores that cater to respiratory devices.

Key players in the global COPD devices market include:

AstraZeneca Plc

Orion Corporation

Mylan N.V.

Boehringer Ingelheim GmbH

Teva Pharmaceutical Industries Ltd.

GlaxoSmithKline plc

Novartis AG

Sunovion Pharmaceuticals, Inc.

CHIESI Farmaceutici SpA

Browse More Reports:

To know more        

Contact Us:


Prophecy Market Insights

📞+1 860 531 2574


🌐 Website-

🌐 Blog-

Follow us on:

LinkedIn | Twitter | Facebook

Your Missed